Structure of circulatory system diseases and their genetic predictors in athletes with high intensity of training and competitive load

Introduction: Morphofunctional changes of the circulatory system organs detected in athletes may remain without due attention, as clinical (phenotypic) signs of pathological abnormalities are very similar to manifestations of cardiovascular system adaptation to intensive physical loads. The aim of the study is to propose a personalized algorithm for biomedical support of professional athletes with abnormalities and diseases of the circulatory organs based on clinical and genomic data.

Materials and methods: The results of in-depth medical examination (2021-2023) of 15,464 athletes who are members of Russian sports teams were analyzed. The structure of circulatory system diseases according to the codes of the International Classification of Diseases, 10th revision (ICD-10), which were included in the summary report of the last examination, was analyzed. Fifty athletes with abnormalities and diseases of the circulatory system organs, experiencing different degrees of intensity of dynamic and static loads in accordance with the Mitchell classification, were selected from the study sample for full genome sequencing and subsequent clinical interpretation of the obtained data.

Results: In the study sample the number of people with pathologic conditions of the circulatory system organs amounted to 6 946 people (45 %). Mitchell classification groups had statistically significant differences with respect to the prevalence of 10 diseases of the circulatory system organs. In 50 DNA samples of professional athletes, 5 probably pathogenic variants (10%), 19 variants with uncertain clinical significance (38%), relevant to the phenotype of a monogenic disease with circulatory system organ damage, were detected.

Conclusion: Molecular genetic testing is an effective tool for differential diagnostics of pathologic and adaptive changes in the organs of the circulatory system. Carrying causative genes in combination with clinical signs allows to change the tactics of medical and biological support of an athlete according to the proposed algorithm.

1. Vershinin E.G., Guro O.A., Goncharova A.A. Comparative analysis of the structure of morbidity of athletes and persons engaged in sports in Volgograd in 2010-2016. Journal of Volgograd State Medical University. 2017;4(64):58–62. (In Russ.).

2. Gorbenko A., Skirdenko Y., Nikolaev N., Zamahina O., Sherstyuk S., Ershov A. Physiological or pathological hypertrophy of athlete’s heart syndrome. Patologiya Krovoobrashcheniya i Kardiokhirurgiya. 2020;24(2):16–25 (In Russ.). https://doi.org/10.21688/1681-3472-2020-2-16-25

3. Baumgartner L., Schulz T., Oberhoffer R., Weberruß H. Influence of Vigorous Physical Activity on Structure and Function of the Cardiovascular System in Young Athletes-The MuCAYA-Study. Front. Cardiovasc. Med. 2019;6:148. https://doi.org/10.3389/fcvm.2019.00148

4. Gavrilova E.A., Churganov O.A., Bryntseva E.V., Larintseva O.S. Heart rhythm disorders as a manifestation of the pathological athletic heart at different stages of sports training. Modern Issues of Biomedicine. 2022;6(1):11 (In Russ.). https://doi.org/10.51871/2588-0500_2022_06_01_11

5. Smolenskiy A.V., Mikhaylova A.V. Cardiology. A National Leadership. Sport and cardiovascular diseases. Cardiology: News. Opinions. Training. 2019;(4):62–65 (In Russ.).

6. Fellmann F., van El C.G., Charron P., Michaud K., Howard H.C., Boers S.N., et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Eur. J. Hum. Genet. 2019;27(12):1763–1773. https://doi.org/10.1038/s41431-019-0445-y

7. Castelletti S., Zorzi A., Ballardini E., Basso C., Biffi A., Brancati F., et al. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology. Int. J. Cardiol. 2022;364:169–177. https://doi.org/10.1016/j.ijcard.2022.05.071

8. Asatryan B., Schaller A., Seiler J., Servatius H., Noti F., Baldinger S.H., et al. Usefulness of Genetic Testing in Sudden Cardiac Arrest Survivors With or Without Previous Clinical Evidence of Heart Disease. Am. J. Cardiol. 2019;123(12):2031–2038. https://doi.org/10.1016/j.amjcard.2019.02.061

9. Lubitz S.A., Ellinor P.T. Next-generation sequencing for the diagnosis of cardiac arrhythmia syndromes. Heart Rhythm. 2015;12(5):1062–1070. https://doi.org/10.1016/j.hrthm.2015.01.011

10. Mitchell J.H., Haskell W., Snell P., Van Camp S.P. Task Force 8: classification of sports. J. Am. Coll. Cardiol. 2005;45(8):1364–1367. https://doi.org/10.1016/j.jacc.2005.02.015

11. bcl2fastq and bcl2fastq2 Conversion Software Downloads [internet]. Available at: https://emea.support.illumina.com/sequencing/sequencing_software/bcl2fastq-conversion-software/downloads.html (accessed 21 November 2022).

12. Sequencing Analysis Viewer Support [internet]. Available at: https://support.illumina.com/sequencing/sequencing_software/sequencing_analysis_viewer_sav.html (accessed 21 November 2022).

13. Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data [internet]. Available at: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/ (accessed 21 November 2022).

14. Krusche P., Trigg L., Boutros P.C., Mason C.E., De La Vega F.M., Moore B.L., et al. Best practices for benchmarking germline small-variant calls in human genomes. Nat. Biotechnol. 2019;37(5):555–560. https://doi.org/10.1038/s41587-019-0054-x

15. Wilde A.A.M., Semsarian C., Márquez M.F., Shamloo A.S., Ackerman M.J., Ashley E.A., et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Europace. 2022;24(8):1307–1367. https://doi.org/10.1093/europace/euac030

16. Human Phenotype Ontology [internet]. Available at: https://hpo.jax.org/app/

17. Wickham H., Bryan J. Readxl: Read Excel Files. R Package Version 1.3.1. 2019. Available at: https://CRAN.R-project.org/package=readxl.

18. George K., Whyte G.P., Green D.J., Oxborough D., Shave R.E., Gaze D., Somauroo J. The endurance athletes heart: acute stress and chronic adaptation. Br. J. Sports Med. 2012;46(suppl 1):i29-i36. https://doi.org/10.1136/bjsports-2012-091141

19. Pujadas S., Doñate M., Li C.H., Merchan S., Cabanillas A., Alomar X., et al. Myocardial remodelling and tissue characterisation by cardiovascular magnetic resonance (CMR) in endurance athletes. BMJ Open Sport Exerc. Med. 2018;4(1):e000422. https://doi.org/10.1136/bmjsem-2018-000422

20. Domenech-Ximenos B., Sanz-de la Garza M., Prat-González S., Sepúlveda-Martínez A., Crispi F., Duran-Fernandez K., et al. Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes. J. Cardiovasc. Magn. Reson. 2020;22(1):62. https://doi.org/10.1186/s12968-020-00660-w

21. Wickham H. ggplot2. WIREs Computational Statistics. 2011;3(2):180–185. https://doi.org/10.1002/wics.147

22. Dixon P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 2003;14(6):927–930. https://doi.org/10.1111/j.1654-1103.2003.tb02228.x

23. Gavrilova E. Actual problems of sports cardiology. Moscow: Sport Publ.; 2022 (In Russ.).

24. Larsson E., Wesslén L., Lindquist O., Baandrup U., Eriksson L., Olsen E., Rolf C., Friman G. Sudden unexpected cardiac deaths among young Swedish orienteers — Morphological changes in hearts and other organs. APMIS. 1999;107(3):325–336. https://doi.org/10.1111/j.1699-0463.1999.tb01561.x

25. Masson E., Zou W.B., Génin E., Cooper D.N., Gac G.L., Fichou Y., et al. Expanding ACMG variant classification guidelines into a general framework. Hum. Genomics. 2022;16(1):31. https://doi.org/10.1186/s40246-022-00407-x